期刊
CELL COMMUNICATION AND SIGNALING
卷 18, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12964-020-00542-9
关键词
Efferocytosis; Tumor progression; Antitumor therapy; Immunosuppression; Phosphatidylserine; Phosphatidylserine receptor; CD47
类别
资金
- China Postdoctoral Science Foundation [2017 M612010]
- National Natural Science Foundation of China [81701144]
Efferocytosis is a physiologic phagocytic clearance of apoptotic cells, which modulates inflammatory responses and the immune environment and subsequently facilitates immune escape of cancer cells, thus promoting tumor development and progression. Efferocytosis is an equilibrium formed by perfect coordination among find-me, eat-me and don't-eat-me signals. These signaling pathways not only affect the proliferation, invasion, metastasis, and angiogenesis of tumor cells but also regulate adaptive responses and drug resistance to antitumor therapies. Therefore, efferocytosis-related molecules and pathways are potential targets for antitumor therapy. Besides, supplementing conventional chemotherapy, radiotherapy and other immunotherapies with efferocytosis-targeted therapy could enhance the therapeutic efficacy, reduce off-target toxicity, and promote patient outcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据